SCHEMBL6803769

SCHEMBL6803769

Nc1ccc(Nc2ccc([N+](=O)[O-])cn2)cc1

nearest known ligand 0.73

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.73
KMT2A Q03164 10/20 0.73
ALOX12 P18054 1/20 0.73
MAPT P10636 7/20 0.72
LMNA P02545 1/20 0.72
RAB9A P51151 5/20 0.68
NPC1 O15118 3/20 0.68
ALDH1A1 P00352 2/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
PABPC1 P11940 1/20 0.60
KDM4E B2RXH2 1/20 0.57
ROCK1 Q13464 1/20 0.55
PKM P14618 1/20 0.53
MAPK1 P28482 1/20 0.52
CYP1A2 P05177 1/20 0.51
GAA P10253 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10709186 0.84 MEN1 (0.73) MEN1KMT2AALOX12MAPTLMNA
SCHEMBL912778 0.84 MEN1 (1.00) MEN1KMT2AALOX12MAPTLMNA
SCHEMBL5800553 0.84 MEN1 (0.73) MEN1KMT2AALOX12MAPTLMNA
SCHEMBL20303457 0.84 KMT2A (0.64) MEN1KMT2AALOX12MAPTLMNA
SCHEMBL913813 0.84 MEN1 (1.00) MEN1KMT2AALOX12MAPTLMNA
SCHEMBL20796131 0.83 MEN1 (0.74) MEN1KMT2AALOX12MAPTLMNA
SCHEMBL25826203 0.83 MEN1 (0.74) MEN1KMT2AALOX12MAPTLMNA
Methane SCHEMBL27598399 0.83 MEN1 (0.97) MEN1KMT2AALOX12MAPTLMNA
SCHEMBL20936286 0.82 MEN1 (0.71) MEN1KMT2AALOX12MAPTLMNA
SCHEMBL21774482 0.81 MEN1 (0.64) MEN1KMT2AALOX12MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667843-B2 Liquid crystal alignment agent composition, method of preparing liquid crystal alignment film, and liquid crystal alignment film, and liquid crystal display using the same LG CHEM, LTD. (KR) 2023-06-06 US disclosed
US-11667844-B2 Liquid crystal alignment composition, method of preparing liquid crystal alignment film, and liquid crystal alignment film, and liquid crystal display using the same LG CHEM, LTD. (KR) 2023-06-06 US disclosed
EP-3620492-B1 LIQUID CRYSTAL ALIGNMENT AGENT COMPOSITION, METHOD FOR PREPARING LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY USING SAME LG CHEMICAL LTD (KR) 2023-03-29 EP disclosed
US-11592713-B2 Liquid crystal aligning agent composition, method for preparing liquid crystal alignment film using same, and liquid crystal alignment film and liquid crystal display device using same LG CHEM, LTD. (KR) 2023-02-28 US disclosed
US-11441075-B2 Liquid crystal alignment agent composition, method of producing liquid crystal alignment film using the same, and liquid crystal alignment film using the same LG CHEM, LTD. (KR) 2022-09-13 US disclosed
US-11352563-B2 Liquid crystal aligning agent composition, method for preparing liquid crystal alignment film using same, and liquid crystal alignment film using same LG CHEM, LTD. (KR) 2022-06-07 US disclosed
US-11345782-B2 Copolymer for liquid crystal alignment agent, liquid crystal alignment agent including the same, and liquid crystal alignment film and liquid crystal display device using the same LG CHEM, LTD. (KR) 2022-05-31 US disclosed
US-11307462-B2 Liquid crystal aligning agent composition, method for preparing liquid crystal alignment film using same, and liquid crystal alignment film and liquid crystal display using same LG CHEM, LTD. (KR) 2022-04-19 US disclosed
US-11209699-B2 Liquid crystal aligning agent composition, method for preparing liquid crystal alignment film using same, and liquid crystal alignment film using same LG CHEM, LTD. (KR) 2021-12-28 US disclosed
US-11149204-B2 Liquid crystal alignment agent composition, method for preparing liquid crystal alignment film using same, and liquid crystal alignment film and liquid crystal display using same LG CHEM, LTD. (KR) 2021-10-19 US disclosed
US-20200208055-A1 COPOLYMER FOR LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT AGENT INCLUDING THE SAME, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME LG CHEM, LTD. (KR) 2020-07-02 US disclosed
US-20200190405-A1 LIQUID CRYSTAL ALIGNMENT AGENT COMPOSITION, METHOD FOR PREPARING LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY USING SAME LG CHEM, LTD. (KR) 2020-06-18 US disclosed
US-20200165522-A1 LIQUID CRYSTAL ALIGNMENT AGENT COMPOSITION, METHOD OF PRODUCING LIQUID CRYSTAL ALIGNMENT FILM USING THE SAME, AND LIQUID CRYSTAL ALIGNMENT FILM USING THE SAME LG CHEM, LTD. (KR) 2020-05-28 US disclosed
US-20200124922-A1 LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR PREPARING LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY USING SAME LG CHEM, LTD. (KR) 2020-04-23 US disclosed
US-20200063035-A1 LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR PREPARING LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL ALIGNMENT FILM USING SAME LG CHEM, LTD. (KR) 2020-02-27 US disclosed
US-20190256778-A1 LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR PREPARING LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL ALIGNMENT FILM USING SAME LG CHEM, LTD. (KR) 2019-08-22 US disclosed
WO-2019078535-A2 LIQUID CRYSTAL ALIGNMENT AGENT COMPOSITION, METHOD FOR PRODUCING LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL ALIGNMENT FILM USING SAME 주식회사 엘지화학 2019-04-25 WO disclosed
US-6794378-B2 ANTIINFLAMMATORY AGENTS AJINOMOTO CO., INC. (JP) 2004-09-21 US disclosed
US-20020133005-A1 Heterocyclic compounds and medical use thereof AJINOMOTO CO., INC. (JP) 2002-09-19 US disclosed
EP-1193255-A1 HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF Ajinomoto Co., Inc. (JP) 2002-04-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020133005-A1 Heterocyclic compounds and medical use thereof NFKBIA, CHUK, RELA MEN1 3117/4885KMT2A 3137/4885ALOX12 274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.